IUPHAR - invited review - Ibogaine - A legacy within the current renaissance of psychedelic therapy.

Mash, Deborah C

Mash, Deborah C.

Affiliation

Mash DC; Professor Emerita University of Miami Miller School of Medicine, Depts. Neurology and Molecular and Cellular Pharmacology. Electronic address: dmash@med.miami.edu.

Pharmacol Res ; 190: 106620, 2023 04.

Article in En | MEDLINE | ID: mdl-36907284

Subject(s)

Hallucinogens; Ibogaine; Substance Withdrawal Syndrome; Substance-Related Disorders; Animals; Humans; Ibogaine/pharmacology; Ibogaine/therapeutic use; Hallucinogens/therapeutic use; Substance-Related Disorders/drug therapy; Substance Withdrawal Syndrome/drug therapy; Analgesics, Opioid/therapeutic use

Key words

Addiction drug therapy; CYP2D6; Hallucinogen; Noribogaine; Opioid Use Disorder; Polypharmacology; Psychedelic; QT interval

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Substance Withdrawal Syndrome / Substance-Related Disorders / Hallucinogens / Ibogaine Type of study: Prognostic_studies Language: En Journal: Pharmacol Res Year: 2023 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google